Life Sciences

This issue profiles a fully integrated, high capacity, next generation sequencing system; an ebola diagnostic kit by China that has been approved by the WHO; and CRISPR associated protein 9 mediated gene editing in human embryo.

This issue profiles recent advances and opportunities for innovation in drug-eluting stents.

This issue profiles a molecular pathway that holds the key to suppress children's cancer, destroying chemical weapons safely, and R&D on datacenter cabling at HP Laboratories.

This issue profiles an affordable and customisable radiotherapy system, a remote telerobotic ultrasound imaging platform, and affordable digital radiography systems for low-income countries.

This issue profiles cancerous growth inhibited by a kinase inhibitor, patient-driven oncological therapeutic solutions using cancer genomic foundation, and multiple kinase inhibitors targeting oncological disorders that are currently in clinical trials.

China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...

This issue profiles using an annuloplasty ring to treat mitral regurgitation, a novel leadless artificial cardiac pacemaker, and 3D printed medical devices that are on the rise.

This issue profiles a genome editing technology for treatment of blood cancer, a genetic risk assessment test for non-hereditary breast cancer, and rapid detection of infectious disease through innovations in molecular diagnostics.

This issue profiles a novel drug developed for treatment of insomnia, a drug for treating swimmer’s ear receives that FDA approval, and development of an advanced drug for chronic weight management.